Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
Testosterone (T) therapy in older men with low serum T levels increases lean body mass and decreases fat mass. These changes might improve physical performance and strength; however, it has not been established whether T therapy improves functional outcome in older men. Moreover, concerns exist about the impact of T therapy on the prostate in older men. The administration of finasteride (F), which partially blocks the conversion of T to the more potent androgen, dihydrotestosterone, attenuates the impact of T replacement on prostate size and prostate-specific antigen. We hypothesized that T replacement in older, hypogonadal men would improve physical function and that the addition of F to this regimen would continue to provide the T-induced improvements in physical performance, strength, and body composition. Seventy men with low serum T (<350 ng/dl), age 65 yr and older, were randomly assigned to receive one of three regimens for 36 months: 1) T enanthate, 200 mg im every 2 wk, with placebo pills daily (T-only); 2) T enanthate, 200 mg every 2 wk, with 5 mg F daily (T + F); or 3) placebo injections and pills (placebo). We obtained serial measurements of timed physical performance, grip strength, lower extremity strength, body composition (by dual-energy x-ray absorptiometry), fasting cholesterol profiles, and hormones. Fifty men completed the 36-month protocol. After 36 months, T therapy significantly improved performance in a timed functional test when compared with baseline and placebo [4.3 +/- 1.6% (mean +/- sem, T-only) and 3.8 +/- 1.0% (T + F) vs. -5.6 +/- 1.9% for placebo (P < 0.002 for both T and T + F vs. placebo)] and increased handgrip strength compared with baseline and placebo (P < 0.05). T therapy increased lean body mass [3.77 +/- 0.55 kg (T-only) and 3.64 +/- 0.56 kg (T + F) vs. -0.21 +/- 0.55 kg for placebo (P < 0.0001)], decreased fat mass, and significantly decreased total cholesterol, low-density lipoprotein, and leptin, without affecting high-density lipoprotein, adiponectin, or fasting insulin levels. These results demonstrate that T therapy in older men with low serum T improves physical performance and strength over 36 months, when administered alone or when combined with F, and suggest that high serum levels of dihydrotestosterone are not essential for these beneficial effects of T in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elsewhere, testosterone-associated increases in lean mass were accompanied by improvements in handgrip strength, knee extension and leg press and chest press exercises415,416.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [416]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increasing serum testosterone levels to low- to mid-normal ranges through the administration of testosterone for several months in healthy older men resulted in increased muscle strength (133–136) and improved physical performance (134, 135).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [134]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Upon testosterone administration there is a decrease in fat mass and an increase in lean body mass and the net result is often, but not always, that total body weight does not show major changes.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [17]
In the citing paper
“Most randomized, placebo-controlled trials have indicated that T treatment increases lean mass and reduces fat mass in men with low serum T [2–7]”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
In the citing paper
“but the overall effect on body weight and BMI in men with different T-status is inconsistent.”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · cited 1×
“High levels of adiponectin have been suggested to be cardioprotective (44) and are associated with increased insulin sensitivity (45).”
BackgroundLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundYang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundMuscle strength and speed of movement in relation to age and muscle morphology
Larsson, L., Grimby, G., & Karlsson, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.3.451 · Cited by 1,135
A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women
Frontera, W. R., Hughes, V. A., Lutz, K. J., & Evans, W. J. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.2.644 · Cited by 1,011
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Such changes in body composition are likely due to increases in muscle mass, as has been reported in younger men receiving T (33).”
Result
Cited by
Items 501–576 of 576
El-Hafiz, M. A., Zaky, A. M., El-Shahed, A. R., & Al-Shorbagy, M. S. I. (2022) · Al-Azhar Medical Journal · doi:10.21608/amj.2022.240691 · Cited by 1
“In contrast, testosterone replacement in older men with low serum testosterone compared with young healthy men, increases lean body mass and decreases fat mass, total cholesterol, and low-density lipoprotein without affecting high density lipoprotein (Page et al., 2010) .”
BackgroundIyer, R., & Handelsman, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_23 · Cited by 1
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Morales, Á., Kaufmann, J. M., Legros, J.-J., Lunenfeld, B., et al. (2010) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 3
Barros, L. B. (2014) · Cited by 1
State of the Art Reviews : Male Menopause: Fact or Fiction?
Wald, M., Miner, M. M., & Seftel, A. D. (2008) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607311513 · Cited by 1
Management of hyperlipidemia in the elderly
Kozaki, K. (2007) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.44.181 · Cited by 1
Andropause: Need for concrete guidelines until more evidence becomes available
Basaria, S. S. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347269 · Cited by 1
Giornale Italiano di MEDICINA SESSUALE e RIPRODUTTIVA
Pescatori, E. S., Gentile, V., Franco, G., Farina, F. P., & Salonia, A. (2007) · Cited by 1
The interrelationship of sex steroid levels, body composition and bone characteristics in men
Lapauw, B. (2009) · Ghent University Academic Bibliography (Ghent University)
Kristianingrum, Y. P. (2014)
Meriggiola, M. C., Armillotta, F., Altieri, P., Costantino, A., Cerpolini, S., Berra, M., Perrone, A. M., Saad, F., & Pelusi, G. (2008) · Sexologies · doi:10.1016/s1158-1360(08)72735-x · Cited by 2
Reply to the paper assessment of screening evaluations is not straightforward by Thomas G. Travison
Morley, J. E. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.03.002
Does testosterone supplementation improve health and function in elderly men?
Page, S. T., Amory, J. K., & Matsumoto, A. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0840
Self-citationWang, C., Nieschlag, E., RONALD, S. S., Behre, H. M., WAYNE, J. H., LOUIS, J. G., JEAN, M. K., Legros, J., Lunenfeld, B., Morales, Á., et al. (2010) · Obesity and metabolism · doi:10.14341/2071-8713-5211
Diagnóstico e Tratamento do Hipogonadismo Masculino Tardio
Alves, M., Neves, C., & Medina, J. L. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Fernandes, N. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
From prenatal life into senescence, testosterone is essential requirement for manhood.
Pradidarcheep, W., & Showpittapornchai, U. (2009) · PubMed · Cited by 1
T in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men
Anawalt, B. D. (2006) · US Endocrinology · doi:10.17925/use.2006.00.1.2c
Self-citationElliott, J. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5176
Applegarth, L. D., Oates, R. D., & Schlegel, P. N. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997761.005
The Clinical relevance of serum testosterone and sexual activity in the ageing male
Journals, I., Diya, K., & Bayumi, E. K. (2015) · Figshare · doi:10.6084/m9.figshare.1524128
Sabet, Z. (2012) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2012.453
AUTHOR PROOF COPY Not for publication The many faces of testosterone
Bain, J. (2007) · Cited by 1
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
Self-citationHeidelbaugh, J. J., Grech, A., & Miner, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26091-4_13
Androgen Actions on Bone: Clinical Aspects
Goemaere, S., T'Sjoen, G. G., & Kaufman, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_17 · Cited by 1
Pituitary Gonadal Axis in the Male
Corradi, P. F., Corradi, R. B., & Greene, L. W. (2016)
Münzer, T., Harman, S. M., Sorkin, J. D., Blackman, M. R., Klinik, G., & Pepper, C. D. (2009)
Gianatti, E. (2016) · Minerva Access (University of Melbourne)
Iyer, R., & Handelsman, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_19 · Cited by 1
Psychosocial and Endocrine Antecedents of Responses to Social-Evaluative Stress
Knight, E. L. (2017) · Scholars' Bank (University of Oregon)
O’Leary, M. F. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Hierarchy Negotiation tactics used for Status Attainment are calibrated by Personal Traits
심경옥, & Chun, W. Y. (2015) · 한국심리학회지 사회및성격 · doi:10.21193/kjspp.2015.29.2.002
Thomas, A. G. (2015) · Cronfa (Swansea University) · doi:10.23889/suthesis.41184
Impact of Sarcopenia in Healthy Aging and Suggested Interventions
Erdoğan, T., Bahat, G., & Karan, M. A. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_20
Frailty and anabolic hormones in ageing men
O’Connell, M. D. L. (2011) · Research Explorer (The University of Manchester)
Manafa, P. O., Mouneke, I. G., Ekuma-Okereke, O., Ebugosi, R. S., Chukwuma, G. O., Nc, I., Chukwuanukwu, R., Ogbuowelu, O. S., Okocha, E., Ke, N., et al. (2019) · Acta Scientific Medical Sciences · doi:10.31080/asms.2019.03.0432 · Cited by 1
Park, S., Cho, S., Kim, J. Y., Yeo, J. K., & Park, M. S. (2020) · Journal of Men s Health · doi:10.15586/jomh.v16isp1.248
Testosterone and the aging male: To treat or not to treat?
Baina, J. (2010)
Testosterone replacement in men
Beg, S., Al-Khoury, L., & Cunningham, G. R. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831550c5
Burger, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718106470.793483637
Nonhuman Primate Models of Immunosenescence
Rivera, A., Rais, M., Barr, T., Arnold, N. D., Sureshchandra, S., & Messaoudi, I. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_80-1 · Cited by 1
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Bourey, R. E., Morley, J. E., & McKee, A. M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch81
Lopès, P., & Poudat, F.-X. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-77438-6.00005-x
Hormone Replacement Therapy in Men
Pham, C. H., Wang, C., & Swerdloff, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99449-2
(2015) · Wiley eBooks · doi:10.1002/9781118896068.ch1
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224813.85060.ab
Faculty Opinions recommendation of Treatment of men for "low testosterone": A systematic review.
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726764636.793556540
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726239987.793556570
Hypogonadism and Testosterone Therapy in Elderly Men
Yeap, B. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66168-8
Raynor, M., Pinsky, M. R., Chawla, A., & Hellstrom, W. J. G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-916-1_14
Testosterone Therapy in Oncologic Patients
Solsrud, E., Louters, M. M., & Pearlman, A. M. (2023) · Current Sexual Health Reports · doi:10.1007/s11930-022-00351-w
Hypogonadism and testosterone therapy in elderly men
Yeap, B. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00046-7
Missbrauch und Missbrauch von Testosteron
Iyer, R., & Handelsman, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_23
Local estradiol deposition in a rat rotator cuff repair model: proof of concept
Chalmers, P. N., Jurynec, M. J., Hickey, A., Fallin, T. W., Zelada, A. C., Honeggar, M., Hotaling, J. M., Emery, B. R., & Tashjian, R. Z. (2025) · JSES International · doi:10.1016/j.jseint.2025.03.004
Hormone replacement therapy, male
Wang, C., & Swerdloff, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00263-6
Long-Term Effects of Testosterone Therapy in Men with Testosterone Deficiency
Saad, F., & Caliber, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_17
Sofikitis, N., Giwercman, A., Minhas, S., Kaltsas, A., Tharakan, T., Pozzi, E., & Salonia, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-55405-6_57
Testosterone Replacement Therapy
Amory, J. K., & Amory, T. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_18
Self-citationLi, Y., Song, G., Ma, J., Li, M., Tan, W., Chen, X., Liu, X., Yin, Y., Liu, S., Li, T., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7542509/v1
Henker, V. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1186
Testosterone Deficiency Syndrome
Meryn, S. (2014) · Springer eBooks · doi:10.1007/978-3-662-45018-5_10
Finasteride lowers cholesterol in humans and delays atherosclerosis progression in Ldlr-/- mice
McQueen, J. P. (2021) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Méthodologies et technologies pour l'évaluation de la fragilité physique des personnes âgées
Jaber, R. (2014) · theses.fr (ABES) · doi:10.70675/f234e9d0z4995z4c67zb5c1z2566d4d6ffeb · Cited by 1
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2 · Cited by 1
Park, D. J., Lee, S. W., Park, S., & Lee, J. H. (2026) · The World Journal of Men s Health · doi:10.5534/wjmh.250435
Update on testosterone deficiency and therapeutic options for testosterone replacement therapy
Thompson, T., Mubarak, M., Jones, T. H., Pearce, I., & Modgil, V. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01190-3 · Cited by 1
Zitzmann, M., Bosnyák, Z., Jones, R. L., & Caliber, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71384
Amalraj, A., Kuppadakath, S. A., Reshna, K. R., C., K. V. A., Balakrishnan, P. L., & Gopi, S. (2026) · ACS Nutrition Science · doi:10.1021/acsnutrsci.6c00093
Effects of Testosterone Treatment in Older Men.
(2018) · PubMed
Metadata
- Authors
- Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L.
- Affiliations
- Emory University (US)
- VA Puget Sound Health Care System (US)
- University of Washington (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 90
- Issue
- 3
- Pages
- 1502-1510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116827517
- Cited by
- 566
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 10 · 2023: 14 · 2022: 20 · 2021: 12 · 2020: 16 · 2019: 26 · 2018: 30 · 2017: 31 · 2016: 29 · 2015: 22 · 2014: 34 · 2013: 24 · 2012: 34
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchWorks at the University of Washington (University of Washington) (submittedVersion)
- Funders
- National Institutes of Health (5r01ag010975-04, HL007028)
- National Institute on Aging (K23AG027238, AG10975)
- National Heart, Lung, and Blood Institute (HL-007028, T32HL007028)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, finasteride, hypogonadism, older men, physical performance, grip strength, lean body mass, body composition, testosterone enanthate, prostate-specific antigen, cholesterol, leptin, functional performance, lower limb strength
- MeSH terms
- Aged, Aged, 80 and over, Aging, Androgens, Body Composition, Double-Blind Method, Drug Therapy, Combination, Enzyme Inhibitors, Humans, Hypogonadism, Insulin, Lipids, Male, Motor Activity, Testosterone, Body Mass Index, Finasteride, Hand Strength, Leptin, Intercellular Signaling Peptides and Proteins, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.